Changes in Circulating miR-375-3p and Improvements in Visceral and Hepatic Fat Contents in Response to Lifestyle Interventions: The CENTRAL Trial

Diabetes Care. 2022 Aug 1;45(8):1911-1913. doi: 10.2337/dc21-2517.

Abstract

Objective: To investigate whether changes in circulating levels of pancreatic islet-related miRNA-375 (miR-375) are related to improved visceral and intrahepatic fat accumulation.

Research design and methods: This study included adults with abdominal obesity from an 18-month weight loss lifestyle intervention trial. Circulating miR-375-3p was measured at baseline and 18 months. MRI was performed (n = 139) to assess 18-month changes in abdominal and intrahepatic fat depots.

Results: Circulating miR-375-3p was related to fasting insulin and insulin resistance in participants with prediabetes. After the interventions, there was a significant increase of miR-375-3p (P < 0.001). Greater increase in miR-375-3p was associated with greater reductions of visceral (P = 0.024) and deep subcutaneous (P < 0.001) adipose tissues and intrahepatic fat content (P = 0.012).

Conclusions: Increases in circulating miR-375-3p were associated with visceral and intrahepatic fat reduction. Changes in circulating pancreatic islet-related miR-375-3p may be linked to improved diabetogenic fat depots during weight loss lifestyle interventions.

Trial registration: ClinicalTrials.gov NCT01530724.

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue*
  • Adult
  • Humans
  • Intra-Abdominal Fat
  • Life Style
  • MicroRNAs* / genetics
  • Obesity
  • Weight Loss / genetics

Substances

  • MIRN375 microRNA, human
  • MicroRNAs

Associated data

  • ClinicalTrials.gov/NCT01530724
  • figshare/10.2337/figshare.19748788